JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Percutaneous Pulmonary Valve Implantation With Self-Expanding Valves for Carcinoid Heart Diseases

  • 0Cardiology Division, Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong SAR.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions +

|

November 18, 2024

|

November 18, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

Carcinoid heart disease, a complication of neuroendocrine tumors, often affects heart valves. Percutaneous pulmonary valve implantation using the VenusP-valve offers a new treatment option for pulmonary regurgitation in these high-risk patients.

Area Of Science

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background

  • Carcinoid heart disease (CHD) is a serious complication of neuroendocrine tumors (NETs), frequently causing right-sided heart valve dysfunction.
  • Surgical valve replacement poses high risks for CHD patients due to comorbidities and advanced metastatic disease, necessitating alternative treatments.
  • Transcatheter valve replacement is common for stenotic lesions, but options for pulmonary regurgitation with dilated pulmonary arteries are limited.

Observation

  • This study reports on three patients with carcinoid heart disease and pulmonary regurgitation.
  • All patients had dilated pulmonary arteries unsuitable for standard balloon-expandable valves.
  • Percutaneous pulmonary valve implantation was performed using the large, self-expanding VenusP-valve platform.

Findings

  • All three cases of percutaneous pulmonary valve implantation with the VenusP-valve were technically successful.
  • The VenusP-valve demonstrated effectiveness in treating pulmonary regurgitation in this challenging patient cohort.
  • Key technical aspects and challenges specific to treating pulmonary regurgitation in CHD were highlighted.

Implications

  • Percutaneous pulmonary valve implantation with the VenusP-valve may be a viable and effective treatment for pulmonary regurgitation in carcinoid heart disease patients.
  • This approach expands treatment options for high-risk patients unsuitable for traditional surgery.
  • Further research into this technique for carcinoid heart disease is warranted.

Keywords: